Nationwide Children's Research News
Viewing: 81-90 of 375 | All
May 27, 2020
How a Network of Hospitals Reduced Average Age at Cerebral Palsy Diagnosis to 9.5 Months
Five hospital systems in the United States have become the first in the world to successfully implement, in clinical practice, international CP diagnosis guidelines that were released in 2017. Their efforts, which resulted in an average decrease of 10 months in time-to-diagnosis, demonstrate the practicality and effectiveness of the guidelines for improving age at diagnosis — a key requirement for early interventions, which can improve CP-related developmental outcomes substantially
May 01, 2020
Nationwide Children’s Hospital Names CEO of Andelyn Biosciences
Nationwide Children's Hospital is pleased to announce Mayo Pujols as CEO of Andelyn Biosciences, an affiliate company that will manufacture gene therapy products for the biotechnology and pharmaceutical industries.
Mar 31, 2020
Head-to-Head Comparison Finds Three Anti-Seizure Drugs Equally Effective for Severe Form of Epilepsy
(COLUMBUS, Ohio) – There are three treatment options commonly used by doctors in the emergency room to treat patients with refractory status epilepticus, severe seizures that continue even after benzodiazepine medications, which are effective in controlling seizures in more than two-thirds of
Mar 06, 2020
Study Shows Promising Approach for the Prevention and Cure of Gonorrhea in Women
(COLUMBUS, Ohio) – In research recently published in mBio, researchers from the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital and Griffith University’s Institute for Glycomics have discovered non-antibiotic (host-targeted) therapies for the effective
Feb 28, 2020
Nationwide Children's Hospital Celebrates Opening of the Big Lots Behavioral Health Pavilion
Nationwide Children’s Hospital held a Community Dedication Celebration of the Big Lots Behavioral Health Pavilion today. At nine stories tall, it is America’s largest and most comprehensive center dedicated exclusively to child and adolescent behavioral and mental health on a pediatric medical campus in the United States.
Dec 12, 2019
Triple Medication Combination Could be Life-changing for Majority of Patients with Cystic Fibrosis
(COLUMBUS, Ohio) – A Phase III clinical trial shows that elexacaftor added to ivacaftor and tezacaftor improves lung function and quality of life in cystic fibrosis patients with the most common genetic mutation, F508del.
Dec 09, 2019
While Study Finds Decrease in Eye Exposures Associated with Household Cleaning Products, Experts Still Urge Proper Storage
A new study conducted by the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children’s Hospital analyzed data regarding eye exposures associated with household cleaning products from 2000 through 2016 and found a decrease in the number of exposures during this period. However, the number of these exposures among young children remains high.
Dec 09, 2019
Study Shows Three-Day Intensive Crisis Intervention is Associated with Reduced Suicidality in Adolescents
When an adolescent is acutely suicidal and cannot safely remain in the community, inpatient psychiatric hospitalization is the traditional intervention. But a lack of appropriate facilities across the United States, combined with an increasing demand for inpatient psychiatric services, means many young people who are at critical risk often cannot get the help they need.
Dec 04, 2019
Redirecting the Natural Immune Response to Disrupt Bacterial Biofilms
(COLUMBUS, Ohio) – Most bacterial species prefer to live in biofilms, where they are protected from antibiotic treatments and can lead to chronic and recurrent diseases in humans.
Nov 26, 2019
Study Finds Increase in Calls to U.S. Poison Control Centers for Natural Psychoactive Substances, Driven by Increase in Marijuana Exposures
A new study conducted by the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children’s Hospital found there were more than 67,300 calls to U.S. Poison Control Centers regarding exposures to natural psychoactive substances. The study looked at calls from January 2000 through December 2017, which totaled an average of 3,743 exposures each year, or approximately 10 calls every day.